Hyperglycemia in aneurysmal subarachnoid hemorrhage: A potentially modifiable risk factor for poor outcome

Journal of Cerebral Blood Flow and Metabolism

Volumn 30, Issue 9, 2010, Pages 1577-1587

  Kruyt, Nyika D ^a,b   Biessels, Geert Jan ^b   Devries, J Hans ^a   Luitse, Merel J A ^b   Vermeulen, Marinus ^a   Rinkel, Gabriel J E ^b   Vandertop, W Peter ^a   Roos, Yvo B ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

diabetes mellitus vasospasm; glucose; hyperglycemia; hypoglycemia; subarachnoid hemorrhage

Indexed keywords

GLUCOSE; INSULIN; LACTIC ACID; PYRUVIC ACID; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ACUTE DISEASE; ANEURYSMAL SUBARACHNOID HEMORRHAGE; BLOOD GLUCOSE MONITORING; BRAIN INJURY; BRAIN METABOLISM; CLINICAL TRIAL; CRITICAL ILLNESS; DRUG SAFETY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HOSPITAL INFECTION; HUMAN; HYPERGLYCEMIA; INSULIN HYPOGLYCEMIA; INSULIN TREATMENT; INTENSIVE CARE UNIT; INTENSIVE INSULIN THERAPY; LACTATE BLOOD LEVEL; MICRODIALYSIS; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RESPIRATORY FAILURE; REVIEW; RISK ASSESSMENT; RISK FACTOR; STROKE; SUBARACHNOID HEMORRHAGE; SYSTEMATIC REVIEW; VASOSPASM; WOUND HEALING IMPAIRMENT; ANIMAL; COMPLICATION; METABOLISM; TREATMENT FAILURE;

ANIMALS; BLOOD GLUCOSE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; RISK FACTORS; SUBARACHNOID HEMORRHAGE; TREATMENT FAILURE;

EID: 77956268975     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/jcbfm.2010.102     Document Type: Review

References (112)

1. Adams Jr HP, Putman SF, Kassell NF, Torner JC (1984) Prevalence of diabetes mellitus among patients with subarachnoid hemorrhage. Arch Neurol 41:1033-1035
2. Andersen BJ, Marmarou A (1992) Post-traumatic selective stimulation of glycolysis. Brain Res 585:184-189
3. Anderson RE, Tan WK, Martin HS, Meyer FB (1999) Effects of glucose and PaO2 modulation on cortical intracellular acidosis, NADH redox state, and infarction in the ischemic penumbra. Stroke 30:160-170
4. Annane D, Cariou A, Maxime V, Azoulay E, Dhonneur G, Timsit JF, Cohen Y, Wolf M, Fartoukh M, Adrie C, Santre C, Bollaert PE, Mathonet A, Amathieu R, Tabah A, Clech C, Mayaud J, Lejeune J, Chevret S (2010) Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAM.A. 303:341-348
5. Arumugam TV, Woodruff TM, Lathia JD, Selvaraj PK, Mattson MP, Taylor SM (2009) Neuroprotection in stroke by complement inhibition and immunoglobulin therapy. Neuroscience 158:1074-1089
6. Badjatia N, Topcuoglu M.A., Buonanno FS, Smith EE, Nogueira RG, Rordorf GA, Carter BS, Ogilvy CS, Singhal AB (2005) Relationship between hyperglycemia and symptomatic vasospasm after subarachnoid hemorrhage. Crit Care Med 33:1603-1609
7. Barth E, Albuszies G, Baumgart K, Matejovic M,Wachter U, Vogt J, Radermacher P, Calzia E (2007) Glucose metabolism and catecholamines. Crit Care Med 35:S508-18
8. Beckman JA, Goldfine AB, Gordon MB, Garrett LA, Creager M.A. (2002) Inhibition of protein kinase Cbeta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans. Circ Res 90:107-111
9. Bederson JB, Connolly Jr ES, Batjer HH, Dacey RG, Dion JE, Diringer MN, Duldner Jr JE, Harbaugh RE, Patel AB, Rosenwasser RH (2009) Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 40:994-1025
10. Bell DA, Strong AJ (2005) Glucose/insulin infusions in the treatment of subarachnoid haemorrhage: a feasibility study. Br J Neurosurg 19:21-24
11. Bemeur C, Ste-Marie L, Desjardins P, Vachon L, Butterworth RF, Hazell AS, Montgomery J (2005) Dehydroascorbic acid normalizes several markers of oxidative stress and inflammation in acute hyperglycemic focal cerebral ischemia in the rat. Neurochem Int 46:399-407
12. Bemeur C, Ste-Marie L, Montgomery J (2007) Increased oxidative stress during hyperglycemic cerebral ischemia. Neurochem Int 50:890-904
13. Bergsneider M, Hovda DA, Shalmon E, Kelly DF, Vespa PM, Martin NA, Phelps ME, McArthur DL, Caron MJ, Kraus JF, Becker DP (1997) Cerebral hyperglycolysis following severe traumatic brain injury in humans: a positron emission tomography study. J Neurosurg 86:241-251
14. Bilotta Intensive Insulin Therapy for Strict Glycemic Control in Neurosurgical Patients: Safety and Efficacy (2010). http://www.clinicaltrials. gov accessed May 2010
15. Bilotta F, Spinelli A, Giovannini F, Doronzio A, Delfini R, Rosa G (2007) The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: a randomized prospective pilot trial. J Neurosurg Anesthesiol 19:156-160
16. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358:125-139
17. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC (2001) Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 32:2426-2432
18. Chamorro A, Hallenbeck J (2006) The harms and benefits of inflammatory and immune responses in vascular disease. Stroke 37:291-293
19. Charpentier C, Audibert G, Guillemin F, Civit T, Ducrocq X, Bracard S, Hepner H, Picard L, Laxenaire MC (1999) Multivariate analysis of predictors of cerebral vasospasm occurrence after aneurysmal subarachnoid hemorrhage. Stroke 30:1402-1408
20. Crompton MR (1963) Hypothalamic lesions following the rupture of cerebral berry aneurysms. Brain 86: 301-314
21. Dankbaar JW, Rijsdijk M, van der Schaaf IC, Velthuis BK, Wermer MJ, Rinkel GJ (2009) Relationship between vasospasm, cerebral perfusion, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Neuroradiology 51:813-819
22. de Courten-Meyers GM, Kleinholz M, Wagner KR, Myers RE (1994) Normoglycemia (not hypoglycemia) optimizes outcome from middle cerebral artery occlusion. J Cereb Blood Flow Metab 14:227-236
23. Dorhout Mees SM, van Dijk GW, Algra A, Kempink DR, Rinkel GJ (2003) Glucose levels and outcome after subarachnoid hemorrhage. Neurology 61:1132-1133
24. Dreier JP, Major S, Manning A, Woitzik J, Drenckhahn C, Steinbrink J, Tolias C, Oliveira-Ferreira AI, Fabricius M, Hartings JA, Vajkoczy P, Lauritzen M, Dirnagl U, Bohner G, Strong AJ (2009) Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage. Brain 132:1866-1881
25. Dumont T, Rughani A, Silver J, Tranmer BI (2009) Diabetes mellitus increases risk of vasospasm following aneurysmal subarachnoid hemorrhage independent of glycemic control. Neurocrit Care 11:183-189
26. el-Kashef H (1996) Hyperglycemia increased the responsiveness of isolated rabbits pulmonary arterial rings to serotonin. Pharmacology 53:151-159
27. Els T, Klisch J, Orszagh M, Hetzel A, Schulte-Monting J, Schumacher M, Lucking CH (2002) Hyperglycemia in patients with focal cerebral ischemia after intravenous thrombolysis: influence on clinical outcome and infarct size. Cerebrovasc Dis 13:89-94
28. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D (2002) Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106:2067-2072
29. Feigin VL, Rinkel GJ, Lawes CM, Algra A, Bennett DA, van GJ, Anderson CS (2005) Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke 36:2773-2780
30. Fergusen S, Macdonald RL (2007) Predictors of cerebral infarction in patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 60:658-667
31. Festa A, DAgostino Jr R, Mykkanen L, Tracy RP, Zaccaro DJ, Hales CN, Haffner SM (1999) Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS). Arterioscler Thromb Vasc Biol 19:562-568
32. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hebert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283-1297
33. Fleming I, Busse R (2003) Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol 284:R1-12
34. Frontera JA, Fernandez A, Claassen J, Schmidt M, Schumacher HC, Wartenberg K, Temes R, Parra A, Ostapkovich ND, Mayer SA (2006) Hyperglycemia after SAH: predictors, associated complications, and impact on outcome. Stroke 37:199-203
35. Garg R, Chaudhuri A, Munschauer F, Dandona P (2006) Hyperglycemia, insulin, and acute ischemic stroke: a mechanistic justification for a trial of insulin infusion therapy. Stroke 37:267-73
36. Gauna C, van den Berghe GH, van der Lely AJ (2005) Pituitary function during severe and life-threatening illnesses. Pituitary 8:213-217
37. Gearhart MM, Parbhoo SK (2006) Hyperglycemia in the critically ill patient. AACN Clin Issues 17:50-55
38. Gentile NT, Vaidyula VR, Kanamalla U, DeAngelis M, Gaughan J, Rao AK (2007) Factor VIIa and tissue factor procoagulant activity in diabetes mellitus after acute ischemic stroke: impact of hyperglycemia. Thromb Haemost 98:1007-1013
39. Germanwala AV, Huang J, Tamargo RJ (2010) Hydrocephalus after aneurysmal subarachnoid hemorrhage. Neurosurg Clin N Am 21:263-270
40. Gray CS, Hildreth AJ, Sandercock PA, OConnell JE, Johnston DE, Cartlidge NE, Bamford JM, James OF, Alberti KG (2007) Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol 6:397-406
41. Gray CS, Scott JF, French JM, Alberti KG, OConnell JE (2004) Prevalence and prediction of unrecognised diabetes mellitus and impaired glucose tolerance following acute stroke. Age Ageing 33:71-77
42. Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A, Dhaliwal R, Henderson WR, Chittock DR, Finfer S, Talmor D (2009) Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CM.A.J 180:821-827
43. Hashemi P, Bhatia R, Nakamura H, Dreier JP, Graf R, Strong AJ, Boutelle MG (2009) Persisting depletion of brain glucose following cortical spreading depression, despite apparent hyperaemia: evidence for risk of an adverse effect of Leaos spreading depression. J Cereb Blood Flow Metab 29:166-175
44. Helbok R, Schmidt JM, Kurtz P, Hanafy KA, Fernandez L, Stuart RM, Presciutti M, Ostapkovich ND, Connolly ES, Lee K, Badjatia N, Mayer SA, Claassen J (2010) Systemic glucose and brain energy metabolism after subarachnoid hemorrhage. Neurocrit Care 12:317-323
45. Hemmen TM, Meyer BC, McClean TL, Lyden PD (2008) Identification of nonischemic stroke mimics among 411 code strokes at the University of California, San Diego, Stroke Center. J Stroke Cerebrovasc Dis 17:23-25
46. Hendryk S, Jarzab B, Josko J (2004) Increase of the IL-1 beta and IL-6 levels in CSF in patients with vasospasm following aneurysmal SAH. Neuro Endocrinol Lett 25:141-147
47. Hirashima Y, Nakamura S, Endo S, Kuwayama N, Naruse Y, Takaku A (1997) Elevation of platelet activating factor, inflammatory cytokines, and coagulation factors in the internal jugular vein of patients with subarachnoid hemorrhage. Neurochem Res 22:1249-1255
48. Hotamisligil GS, Spiegelman BM (1994) Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 43:1271-1278
49. Hunt DG, Ivy JL (2002) Epinephrine inhibits insulinstimulated muscle glucose transport. J Appl Physiol 93:1638-1643
50. Jawerbaum A, Franchi AM, Gonzalez ET, Novaro V, de Gimeno M.A. (1995) Hyperglycemia promotes elevated generation of TXA2 in isolated rat uteri. Prostaglandins 50:47-56
51. Juvela S, Siironen J, Kuhmonen J (2005) Hyperglycemia, excess weight, and history of hypertension as risk factors for poor outcome and cerebral infarction after aneurysmal subarachnoid hemorrhage. J Neurosurg 102:998-1003
52. Katsura K, Asplund B, Ekholm A, Siesjo BK (1992) Extraand intracellular pH in the brain during ischaemia, related to tissue lactate content in normo- and hypercapnic rats. Eur J Neurosci 4:166-176
53. Kernan WN, Viscoli CM, Inzucchi SE, Brass LM, Bravata DM, Shulman GI, McVeety JC (2005) Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke. Arch Intern Med 165:227-233
54. Klose M, Brennum J, Poulsgaard L, Kosteljanetz M, Wagner A, Feldt-Rasmussen U (2010) Hypopituitarism is uncommon after aneurysmal subarachnoid haemorrhage. Clin Endocrinol (Oxf ); 23 January 2010 [e-pub ahead of print] PMID:20105184
55. Kruyt ND, Biessels GJ, de Haan RJ, Vermeulen M, Rinkel GJ, Coert B, Roos YB (2009) Hyperglycemia and clinical outcome in aneurysmal subarachnoid hemorrhage: a meta-analysis. Stroke 40:e424-30
56. Kruyt ND, Roos YW, Dorhout Mees SM, van den Bergh WM, Algra A, Rinkel GJ, Biessels GJ (2008) High mean fasting glucose levels independently predict poor outcome and delayed cerebral ischemia after aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 79:1382-1385
57. Lanzino G (2005) Plasma glucose levels and outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg 102:974-975
58. Lanzino G, Kassell NF, Germanson T, Truskowski L, Alves W (1993) Plasma glucose levels and outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg 79:885-891
59. Latorre JG, Chou SH, Nogueira RG, Singhal AB, Carter BS, Ogilvy CS, Rordorf GA (2009) Effective glycemic control with aggressive hyperglycemia management is associated with improved outcome in aneurysmal subarachnoid hemorrhage. Stroke 40:1644-1652
60. Leão A (1944) Spreading depression of activity in cerebral cortex. J Neurophysiol 7:359-390
61. Li S, Zheng J, Carmichael ST (2005) Increased oxidative protein and DNA damage but decreased stress response in the aged brain following experimental stroke. Neurobiol Dis 18:432-440
62. Martini SR, Kent TA (2007) Hyperglycemia in acute ischemic stroke: a vascular perspective. J Cereb Blood Flow Metab 27:435-451
63. McCord JM (1985) Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312:159-163
64. McGirt MJ, Woodworth GF, Ali M, Than KD, Tamargo RJ, Clatterbuck RE (2007) Persistent perioperative hyperglycemia as an independent predictor of poor outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg 107:1080-1085
65. Meigs JB, Mittleman M.A., Nathan DM, Tofler GH, Singer DE, Murphy-Sheehy PM, Lipinska I, DAgostino RB, Wilson PW (2000) Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. JAM.A. 283:221-228
66. Muralikrishna AR, Hatcher JF (2006) Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radic Biol Med 40:376-387
67. Naidech AM, Levasseur K, Liebling S, Garg RK, Shapiro M, Ault ML, Afifi S, Batjer HH (2010) Moderate hypoglycemia is associated with vasospasm, cerebral infarction, and 3-month disability after subarachnoid hemorrhage. Neurocrit Care 12:181-187
68. Naredi S, Lambert G, Eden E, Zall S, Runnerstam M, Rydenhag B, Friberg P (2000) Increased sympathetic nervous activity in patients with nontraumatic subarachnoid hemorrhage. Stroke 31:901-906
69. Natarajan R, Gu JL, Rossi J, Gonzales N, Lanting L, Xu L, Nadler J (1993) Elevated glucose and angiotensin II increase 12-lipoxygenase activity and expression in porcine aortic smooth muscle cells. Proc Natl Acad Sci USA 90:4947-4951
70. Nieuwkamp DJ, Setz LE, Algra A, Linn FH, de Rooij NK, Rinkel GJ (2009) Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol 8:635-642
71. Obici S, Zhang BB, Karkanias G, Rossetti L (2002) Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 8:1376-1382
72. Oddo M, Schmidt JM, Carrera E, Badjatia N, Connolly ES, Presciutti M, Ostapkovich ND, Levine JM, Le RP, Mayer SA (2008) Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study. Crit Care Med 36:3233-3238
73. Osuka K, Suzuki Y, Tanazawa T, Hattori K, Yamamoto N, Takayasu M, Shibuya M, Yoshida J (1998) Interleukin-6 and development of vasospasm after subarachnoid haemorrhage. Acta Neurochir (Wien) 140:943-951
74. Pandolfi A, Giaccari A, Cilli C, Alberta MM, Morviducci L, De Filippis EA, Buongiorno A, Pellegrini G, Capani F, Consoli A (2001) Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat. Acta Diabetol 38:71-76
75. Parsons MW, Barber PA, Desmond PM, Baird TA, Darby DG, Byrnes G, Tress BM, Davis SM (2002) Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol 52:20-28
76. Payne RS, Tseng MT, Schurr A (2003) The glucose paradox of cerebral ischemia: evidence for corticosterone involvement. Brain Res 971:9-17
77. Plomgaard P, Bouzakri K, Krogh-Madsen R, Mittendorfer B, Zierath JR, Pedersen BK (2005) Tumor necrosis factoralpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes 54:2939-2945
78. Rao AK, Chouhan V, Chen X, Sun L, Boden G (1999) Activation of the tissue factor pathway of blood coagulation during prolonged hyperglycemia in young healthy men. Diabetes 48:1156-1161
79. Rask-Madsen C, Dominguez H, Ihlemann N, Hermann T, Kober L, Torp-Pedersen C (2003) Tumor necrosis factoralpha inhibits insulins stimulating effect on glucose uptake and endothelium-dependent vasodilation in humans. Circulation 108:1815-1821
80. Roos YB, de Haan RJ, Beenen LF, Groen RJ, Albrecht KW, Vermeulen M (2000) Complications and outcome in patients with aneurysmal subarachnoid haemorrhage: a prospective hospital based cohort study in the Netherlands. J Neurol Neurosurg Psychiatry 68:337-341
81. Rosengart AJ, Schultheiss KE, Tolentino J, Macdonald RL (2007) Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage. Stroke 38:2315-2321
82. Sarrafzadeh A, Haux D, Kuchler I, Lanksch WR, Unterberg AW (2004) Poor-grade aneurysmal subarachnoid hemorrhage: relationship of cerebral metabolism to outcome. J Neurosurg 100:400-406
83. Schlenk F, Graetz D, Nagel A, Schmidt M, Sarrafzadeh AS (2008a) Insulin-related decrease in cerebral glucose despite normoglycemia in aneurysmal subarachnoid hemorrhage. Crit Care 12:R9
84. Schlenk F, Nagel A, Graetz D, Sarrafzadeh AS (2008b) Hyperglycemia and cerebral glucose in aneurysmal subarachnoid hemorrhage. Intensive Care Med 34: 1200-1207
85. Schlenk F, Vajkoczy P, Sarrafzadeh A (2009) Inpatient hyperglycemia following aneurysmal subarachnoid hemorrhage: relation to cerebral metabolism and outcome. Neurocrit Care 11:56-63
86. Schneider HJ, Kreitschmann-Andermahr I, Ghigo E, Stalla GK, Agha A (2007) Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a systematic review. JAM.A. 298:1429-1438
87. Schwartz MW, Porte Jr D (2005) Diabetes, obesity, and the brain. Science 307:375-9
88. Seematter G, Binnert C, Martin JL, Tappy L (2004) Relationship between stress, inflammation and metabolism. Curr Opin Clin Nutr Metab Care 7:169-173
89. Siesjo BK (1988) Acidosis and ischemic brain damage. Neurochem Pathol 9:31-88
90. Stegenga ME, van der Crabben SN, Levi M, de Vos AF, Tanck MW, Sauerwein HP, van der Poll T (2006) Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinolysis in healthy humans. Diabetes 55:1807-1812
91. Strong AJ, Smith SE, Whittington DJ, Meldrum BS, Parsons AA, Krupinski J, Hunter AJ, Patel S, Robertson C (2000) Factors influencing the frequency of fluorescence transients as markers of peri-infarct depolarizations in focal cerebral ischemia. Stroke 31:214-222
92. Suh SW, Shin BS, Ma H, Van Hoecke M, Brennan AM, Yenari M.A., Swanson RA (2008) Glucose and NADPH oxidase drive neuronal superoxide formation in stroke. Ann Neurol 64:654-663
93. Thiele RH, Pouratian N, Zuo Z, Scalzo DC, Dobbs HA, Dumont AS, Kassell NF, Nemergut EC (2009) Strict glucose control does not affect mortality after aneurysmal subarachnoid hemorrhage. Anesthesiology 110:603-610
94. Ungerstedt U (1991) Microdialysis-principles and applications for studies in animals and man. J Intern Med 230:365-373
95. Vaidyula VR, Rao AK, Mozzoli M, Homko C, Cheung P, Boden G (2006) Effects of hyperglycemia and hyperinsulinemia on circulating tissue factor procoagulant activity and platelet CD40 ligand. Diabetes 55:202-208
96. Vallance P, Collier J, Moncada S (1989) Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 2:997-1000
97. van den Berghe G, Schetz M, Vlasselaers D, Hermans G, Wilmer A, Bouillon R, Mesotten D (2009) Clinical review: intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target? J Clin Endocrinol Metab 94:3163-3170
98. van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ (2005) Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 64:1348-1353
99. van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R (2006) Intensive insulin therapy in the medical ICU. N Engl J Med 354:449-461
100. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359-1367
101. van Gijn J, Kerr RS, Rinkel GJ (2007) Subarachnoid haemorrhage. Lancet 369:306-318
102. Vancheri F, Curcio M, Burgio A, Salvaggio S, Gruttadauria G, Lunetta MC, Dovico R, Alletto M (2005) Impaired glucose metabolism in patients with acute stroke and no previous diagnosis of diabetes mellitus. QJM 98:871-878
103. Vergouwen MD, van GN, de Haan RJ, Kruyt ND, Vermeulen M, Roos YB (2010) Increased cortisol levels are associated with delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Neurocrit Care 12:342-345
104. Vergouwen MD, Vermeulen M, Coert BA, Stroes ES, Roos YB (2008) Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia. J Cereb Blood Flow Metab 28:1761-1770
105. Vespa P, Boonyaputthikul R, McArthur DL, Miller C, Etchepare M, Bergsneider M, Glenn T, Martin N, Hovda D (2006) Intensive insulin therapy reduces microdialysis glucose values without altering glucose utilization or improving the lactate/pyruvate ratio after traumatic brain injury. Crit Care Med 34:850-856
106. Vespa PM (2006) The implications of cerebral ischemia and metabolic dysfunction for treatment strategies in neurointensive care. Curr Opin Crit Care 12:119-123
107. Vespa PM(2008) Intensive glycemic control in traumatic brain injury: what is the ideal glucose range? Crit Care 12:175
108. Vriesendorp TM, DeVries JH, Holleman F, Dzoljic M, Hoekstra JB (2005) The use of two continuous glucose sensors during and after surgery. Diabetes Technol Ther 7:315-322
109. Wagner KR, Kleinholz M, de Court GM, Myers RE (1992) Hyperglycemic versus normoglycemic stroke: topography of brain metabolites, intracellular pH, and infarct size. J Cereb Blood Flow Metab 12:213-222
110. Wang Q, Tang XN, Yenari M.A. (2007) The inflammatory response in stroke. J Neuroimmunol 184:53-68
111. Williams SB, Goldfine AB, Timimi FK, Ting HH, Roddy M.A., Simonson DC, Creager M.A. (1998) Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 97:1695-1701
112. Xu J, Kim HT, Ma Y, Zhao L, Zhai L, Kokorina N, Wang P, Messina JL (2008) Trauma and hemorrhage-induced acute hepatic insulin resistance: dominant role of tumor necrosis factor-alpha. Endocrinology 149:2369-2382